200
Participants
Start Date
April 16, 2025
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2031
Opioid
Subjects will receive oral oxycodone as needed for pain which will be titrated weekly based on pain response, adverse effects, and patient preference. Subjects with intolerance to oxycodone will receive the equivalent dosing of morphine as an alternative.
Opioid Placebo
Subjects will receive a placebo capsule identical to oxycodone, which will similarly be titrated weekly. Subjects with intolerance to the first placebo will receive another placebo capsule identical to morphine.
RECRUITING
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER